(WASHINGTON, D.C.) — The Consumer Healthcare Products Association (CHPA) highlights the results of a recent five-state survey from the Asthma and Allergy Foundation of America (AAFA), which found that consumers on the whole, prefer full access to over-the-counter medicine containing pseudoephedrine (PSE).
Among the results of the survey AAFA found that:
- 98 percent of respondents who had cold, cough, and flu purchase non-prescription medication to treat their ailments.
- 88 percent of respondents living with nasal allergies purchase non-prescription medication to treat their ailments.
- 92 percent of all respondents want access to all of the medications available to them to purchase at the full-service pharmacy which they shop at.
- 84 percent of all respondents want access to all of the medications available to them to purchase at the full-service pharmacy which they shop at, even if they are not currently using them
“These survey findings survey underscore the importance of consumer choice,” said Scott Melville, President and CEO of CHPA. “CHPA is a longtime advocate for consumers, ensuring they maintain access to the pseudoephedrine products that they rely on. At the same time, state legislatures around the country have stood up for the rights of law-abiding cold and allergy sufferers by continually rejecting calls to restrict access to medications containing PSE. It is important that regular consumers are not punished simply because a criminal minority uses PSE improperly, and the survey of the Asthma and Allergy Foundation of America affirms this.”
